tiprankstipranks
Catalyst Pharma (CPRX)
NASDAQ:CPRX
US Market

Catalyst Pharma (CPRX) Technical Analysis

Compare
2,252 Followers

Technical Sentiment

Overall Consensus
Buy
9Bullish
0Neutral
4Bearish
Technical Analysis Consensus
Strong Buy
1Bullish
0Neutral
0Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Catalyst Pharma’s (CPRX) Moving Averages Convergence Divergence (MACD) indicator is 0.71, suggesting Catalyst Pharma is a Sell.
Catalyst Pharma’s (CPRX) 20-Day exponential moving average is 23.61, while Catalyst Pharma’s (CPRX) share price is $24.11, making it a Buy.
Catalyst Pharma’s (CPRX) 50-Day exponential moving average is 22.87, while Catalyst Pharma’s (CPRX) share price is $24.11, making it a Buy.

Catalyst Pharma (CPRX) Pivot Points

Apr 05, 2025, 04:27 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
22.70
23.11
23.68
24.09
24.66
25.07
25.64
Fibonacci
23.11
23.48
23.72
24.09
24.46
24.70
25.07
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Catalyst Pharma (CPRX) Moving Averages

Apr 05, 2025, 04:27 PM
Period
Simple
Exponential
MA5
24.29Sell
24.30Sell
MA10
24.71Sell
24.16Sell
MA20
23.17Buy
23.61Buy
MA50
22.75Buy
22.87Buy
MA100
22.31Buy
22.14Buy
MA200
20.61Buy
20.40Buy
Catalyst Pharma’s (CPRX) 10-Day exponential moving average is 24.16, while Catalyst Pharma’s (CPRX) share price is $24.11, making it a Sell.
Catalyst Pharma’s (CPRX) 100-Day exponential moving average is 22.14, while Catalyst Pharma’s (CPRX) share price is $24.11, making it a Buy.
Catalyst Pharma’s (CPRX) stock price is $24.11 and Catalyst Pharma’s (CPRX) 50-day simple moving average is 22.75, creating a Buy signal.
Catalyst Pharma’s (CPRX) stock price is $24.11 and Catalyst Pharma’s (CPRX) 100-day simple moving average is 22.31, creating a Buy signal.
Catalyst Pharma’s (CPRX) stock price is $24.11 and Catalyst Pharma’s (CPRX) 200-day simple moving average is 20.61, creating a Buy signal.

Catalyst Pharma (CPRX) Technical Indicators

Apr 05, 2025, 04:27 PM
Name
Value
Implied Action
RSI (14)
55.79
Neutral
STOCH (9,6)
55.45
Neutral
STOCHRSI (14)
66.54
Neutral
MACD (12,26)
0.71
Sell
ADX (14)
23.57
Neutral
Williams %R
-40.82
Buy
CCI (14)
51.43
Neutral
ATR (14)
0.90
-
Ultimate Oscillator
54.37
Neutral
ROC
14.70
Buy
Catalyst Pharma’s (CPRX) Relative Strength Index (RSI) is 55.79, creating a Neutral signal.
Catalyst Pharma’s (CPRX) Trend Strength Indicator (ADX) is 23.57, creating a Neutral signal.
Catalyst Pharma’s (CPRX) Commodity Channel Index (CCI) is 51.43, creating a Neutral signal.
Catalyst Pharma’s (CPRX) Price Rate of Change (ROC) is 14.70, creating a Buy signal.

FAQ

Is CPRX a Buy, Hold, or Sell?
Based on CPRX’s technical indicators, CPRX is a Buy.
    What is CPRX’s RSI (14)?
    CPRX’s RSI (14) is 55.79, which suggests CPRX is a Neutral.
      What is CPRX’s MACD?
      CPRX’s MACD is 0.71, which suggests CPRX is a Sell.
        What is CPRX’s 5-day moving average?
        CPRX’s 5-day moving average is 24.29, which suggests CPRX is a Sell.
          What is CPRX’s 20-day moving average?
          CPRX 20-day moving average is 23.17, which suggests CPRX is a Buy.
            What is CPRX’s 50-day moving average?
            CPRX’s 50-day moving average is 22.75, which suggests CPRX is a Buy.
              What is CPRX’s 200-day moving average?
              CPRX’s 200-day moving average is 20.61, which suggests CPRX is a Buy.
                What is CPRX’s Williams % R (14)?
                CPRX’s Williams % R (14) is -40.82, which suggests CPRX is a Buy.
                  What is CPRX’s CCI (14)?
                  CPRX’s CCI (14) is 51.43, which suggests CPRX is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis